The Indian Journal of Pediatrics

, Volume 80, Issue 8, pp 659–662 | Cite as

Prevalence and Risk Factors for Hepatitis C Virus, Hepatitis B Virus, and Human Immunodeficiency Virus in Transfused Children in Kinshasa

  • M. Katabuka
  • M. E. Mafuta
  • A. M. Ngoma
  • P. Mutombo Beya
  • S. Yuma
  • L. Aketi
  • K. P. Kayembe
  • J. R. Gini
Original Article



To determine seroprevalence of hepatitis C virus (HCV), human immunodeficiency virus (HIV), and hepatitis B virus (HBV) and associated factors among transfused children.


A multicenter cross-sectional study of transfused children aged between 18 mo and 13 y old was conducted in 4 hospitals in Kinshasa. Blood samples were collected for the detection of Hepatitis B surface antigen (HBsAg) and antibodies to HCV, HIV 1and 2.


A total of 177 (47.7 %) boys and 194 (52.3 %) girls participated in the study. The median age was 59.5 mo (Interquartile range IQR = 60.6). The prevalence rates of HCV, HBV, and HIV infection were 13.5 %, 1.6 %, and 1.3 %, respectively. Frequency of transfusion events were significantly associated with HCV (p < 0.001) and HIV (p < 0.05) infections.


HCV infection was by far more frequently identified than HBV and HIV infections among Congolese transfused children. Frequency of transfusion events was the only significant risk factor associated with HCV and HIV infections but not for HBV.


Hepatitis C virus Human immunodeficiency virus Hepatitis B virus Transfusion Children 


  1. 1.
    Dhingra N, Hafner V. Safety of blood transfusion at the international level: the role of WHO. Transfus Clin Biol. 2006;13:200–2.PubMedCrossRefGoogle Scholar
  2. 2.
    Cunha L, Plouzeau C, Ingrand P, et al. Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique. J Med Virol. 2007;79:1832–40.PubMedCrossRefGoogle Scholar
  3. 3.
    Tapko J, Sam O, Diarra-Nama A. Status of blood safety in the WHO African region: report of the 2004 survey. 2007Google Scholar
  4. 4.
    Bates I, Manyasi G, Medina Lara A. Reducing replacement donors in Sub-Saharan Africa: challenges and affordability. Transfus Med. 2007;17:434–42.PubMedCrossRefGoogle Scholar
  5. 5.
    Marcucci C, Madjdpour C, Spahn DR. Allogeneic blood transfusions: benefit, risks and clinical indications in countries with a low or high human development index. Br Med Bull. 2004;70:15–28.PubMedCrossRefGoogle Scholar
  6. 6.
    Allain JP. Transfusion risks of yesterday and of today. Transfus Clin Biol. 2003;10:1–5.PubMedCrossRefGoogle Scholar
  7. 7.
    Ocak S, Kaya H, Cetin M, Ozturk M. Seroprevalence of hepatitis B and hepatitis C in patients with thalassemia and sickle cell anemia in a long-term follow-up. Arch Med Res. 2006;37:895–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Covas DT, Boturao Neto E, Zago MA. The frequency of blood-born viral infections in a population of polytransfused Brazilian patients. Rev Inst Med Trop Sao Paulo. 1993;35:271–3.PubMedCrossRefGoogle Scholar
  9. 9.
    Schmunis GA, Cruz JR. Safety of the blood supply in Latin America. Clin Microbiol Rev. 2005;18:12–29.PubMedCrossRefGoogle Scholar
  10. 10.
    Schmunis GA, Zicker F, Pinheiro F, Brandling-Bennett D. Risk for transfusion-transmitted infectious diseases in Central and South America. Emerg Infect Dis. 1998;4:5–11.PubMedCrossRefGoogle Scholar
  11. 11.
    Tshilolo LM, Mukendi RK, Wembonyama SO. Blood transfusion rate in Congolese patients with sickle cell anemia. Indian J Pediatr. 2007;74:735–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Shaffer N, Hedberg K, Davachi F, et al. Trends and risk factors for HIV-1 seropositivity among outpatient children, Kinshasa, Zaire. AIDS. 1990;4:1231–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Bloch EM, Vermeulen M, Murphy E. Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges. Transfus Med Rev. 2012;26:164–80.PubMedCrossRefGoogle Scholar
  14. 14.
    Calderón GM, González-Velázquez F, González-Bonilla CR, et al. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico. Transfusion. 2009;49:2200–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Moore A, Herrera G, Nyamongo J, et al. Estimated risk of HIV transmission by blood transfusion in Kenya. Lancet. 2001;358:657–60.PubMedCrossRefGoogle Scholar
  16. 16.
    Ministry of Plan. Enquete Demographique et de santé EDS-RDC 2007. Democratic Republic of Congo. Final report, Kinshasa. 2008.Google Scholar
  17. 17.
    Programme National Multisectoriel de Lutte contre le SIDA (PNMLS). Rapport National de suivi de la declaration d’engagement UNGASS, Kinshasa. 2010.Google Scholar
  18. 18.
    HIV infection diagnostic strategy by WHO, National AIDS program (PNLS). 2007.Google Scholar
  19. 19.
    Candotti D, Allain J-P. Transfusion-transmitted hepatitis B virus infection. J Hepatol. 2009;551:798–809.CrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2012

Authors and Affiliations

  • M. Katabuka
    • 1
  • M. E. Mafuta
    • 2
  • A. M. Ngoma
    • 3
    • 6
  • P. Mutombo Beya
    • 4
  • S. Yuma
    • 5
  • L. Aketi
    • 1
  • K. P. Kayembe
    • 2
  • J. R. Gini
    • 1
  1. 1.Department of PediatricsUniversity of Kinshasa School of MedicineKinshasaJapan
  2. 2.School of Public HealthUniversity of Kinshasa School of MedicineKinshasaJapan
  3. 3.Department of Blood Transfusion and Transplantation ImmunologyFukushima Medical University School of MedicineFukushimaJapan
  4. 4.Department of Environmental and Preventive MedicineShimane UniversityShimaneJapan
  5. 5.Blood Transfusion National ProgramFukushimaJapan
  6. 6.Department of Transfusion Medicine and Transplantation ImmunologySchool of Medicine, Fukushima Medical UniversityFukushima CityJapan

Personalised recommendations